問題 › 競合が顧客を奪っている › 医療提供者
帰属患者の喪失は償還額の問題ではなく位置づけの問題である場合が多く、両者への対応は正反対になります。 医療提供者にとっての問題は一般論とは異なります。38,000件の生活でダウンサイドリスクを受け入れながらエピソードごとのコストデータが不足しているため、そのコストを無視した回答は確実に誤ります。分析は収益ではなくペイヤーミックスとパネル規模から始める必要があります。
帰属患者の喪失は償還額の問題ではなく位置づけの問題である場合が多く、両者への対応は正反対になります。 医療提供者にとっての問題は一般論とは異なります。38,000件の生活でダウンサイドリスクを受け入れながらエピソードごとのコストデータが不足しているため、そのコストを無視した回答は確実に誤ります。分析は収益ではなくペイヤーミックスとパネル規模から始める必要があります。
競合が帰属患者を獲得し始めると、組織内で最初に挙げられる説明は常に償還額です。時折正しいこともありますが、多くの場合、競合は特定の領域でエピソードごとのコストに絞った約束を選び、その中で勝っています。医療部長やCFOには契約交渉の最終項目として償還額に見えるだけです。
区別が重要なのは、対応が両立しないためです。本当に償還額の問題であれば、料率を合わせた上でバリューベース契約全体を再価格設定するか、そのセグメントの喪失を受け入れるしかありません。位置づけの問題であれば、料率を合わせることは貢献度を損ないながら競合の優位性を助けることになります。
判断する方法は地味です。直近で失った20件の帰属患者の理由をセグメント別に記録することです。償還額の問題は全体に現れ、位置づけの問題は特定の領域に集中します。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 失われた帰属患者がパネル全体に均等に広がらず、特定のペイヤーミックスまたはエピソードタイプに集中している
✓ 医療部長またはCFOが、エピソードごとのコスト証明ではなく契約料率の調整権限を求めている
✓ 競合がバリューベース契約で引き受けるエピソードをより小さく特定している
通常、事態を悪化させる対応です。 償還額に合わせながら位置づけを維持し、結果としてプロバイダーごとの貢献度と議論の両方を失うことです。
It is for you if you run or finance a healthcare provider and losses concentrate in one segment or one use case rather than spreading evenly. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on ある医療提供者. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Sell coordinated care bundles directly to self-insured employers using existing clinic density and ASC capacity.
The leak it closes. Bypasses commercial payer take-rate (estimated 15–20% of premium) and prior-authorization friction, reducing denial leakage on these lives to near zero
The assumption it rests on. At least two of the five largest self-insured employers in the two metros will sign a 3-year direct contract within 18 months — the engine put the probability at 0.7.
| Investment required | $2M over 36 months ($800K Year 1, $700K Year 2, $500K Year 3) |
| Expected return | 6.0–9.0× on $2M investment |
| Revenue, year 1 | $0 incremental (pilot setup and first contract negotiations) |
| Revenue, year 2 | $4–6M incremental (2–3 employer contracts, 4,000–6,000 covered lives) |
| Revenue, year 3 | $12–18M incremental (5 employer contracts, 10,000–15,000 covered lives) |
| Exit criteria | Terminate pilot and redeploy 4 FTEs if fewer than 2 employer contracts signed by Month 18 OR if operating margin on employer channel falls below 6% for two consecutive quarters |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 競合ベンチマークと位置づけ, one of 29 engagements the platform runs. For 医療提供者 it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
そのセグメントをその価格で採算が取れる場合に限り、かつ既に高く支払っている顧客の再価格設定も受け入れる場合に限ります。選択的な一致は、市場が気づいた時点で守れない約束になることが通常です。
幅ではなく特定性で対抗します。資金力の優位な競合はどこでも支出で勝てますが、一つの領域で集中することはできません。そのため約束を狭める方が機能セットを広げるより有効です。
正直な回答は製品決定とそのタイムライン、費用であり、マーケティング対応ではありません。メッセージングでは埋められないギャップに1年を費やすことが最も損失の大きい結果です。
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית